Yoon, S., Lee, D. H., & Kim, S. (2017). Gefitinib with pemetrexed as first-line therapy in patients with advanced nonsquamous non-small cell lung cancer with activating epidermal growth factor receptor mutations. Ann Transl Med.
Stile di citazione ChicagoYoon, Shinkyo, Dae Ho Lee, e Sang-We Kim. "Gefitinib With Pemetrexed As First-line Therapy in Patients With Advanced Nonsquamous Non-small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations." Ann Transl Med 2017.
Citazione MLAYoon, Shinkyo, Dae Ho Lee, e Sang-We Kim. "Gefitinib With Pemetrexed As First-line Therapy in Patients With Advanced Nonsquamous Non-small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations." Ann Transl Med 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.